Federal Compounding Law and Health-System Pharmacists

June 12, 2015

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.

This video was taken at ASHP's Summer Meetings and Exposition in June 2015.